AnalystsTara Bancroft
Tara Bancroft's Stock Forecasts

Analyst Ranking
Top 25%
#1399 out of 5550 analysts
Average Return
+20.29%
Win Rate
61%11 out of 18
Risk vs Reward
Poor
Good

Tara Bancroft's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Merus NvMRUS
+148.42%$21.56$53.56
2023-08-21 -
2024-08-21
Buy
Day One Biopharmaceuticals IncDAWN
+103.31%$10.59$21.53
2026-01-13 -
2026-04-23
Strong Buy
Lantheus Holdings IncLNTH
+95.57%$51.74$101.19
2025-09-15 -
2026-08-03
Strong Buy
Harpoon Therapeutics IncHARP
+75.02%$12.81$22.42
2023-11-20 -
2024-01-16
Buy
Protagonist Therapeutics IncPTGX
+63.88%$88.39$144.85
2026-02-26 -
2026-10-30
Strong Buy

Tara Bancroft Analyst Color

Get additional color on Tara Bancroft's coverage of popular stocks

Tara Bancroft's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Protagonist Therapeutics IncPTGX
3Strong Buy$160.00+10.46%Maintains
11 days ago
Incyte CorpINCY
1Strong Buy$140.00+16.29%Maintains
11 days ago
Celcuity IncCELC
1Strong Buy$145.00+109.75%Reiterates
11 days ago
Arcus Biosciences IncRCUS
1Strong BuyN/AN/AInitiates Coverage On
2 months ago
Faeth Therapeutics IncFTH
1Strong BuyN/AN/AInitiates Coverage On
2 months ago
Eyepoint IncEYPT
1Hold$4.00+1,049.43%Downgrades
2 months ago
Urogen Pharma LtdURGN
1Strong Buy$60.00+83.37%Maintains
3 months ago
Lantheus Holdings IncLNTH
2Hold$102.50+2.03%Downgrades
3 months ago
Mineralys Therapeutics IncMLYS
1Strong BuyN/AN/AInitiates Coverage On
6 months ago
Day One Biopharmaceuticals IncDAWN
1Strong Buy$34.00+57.92%Initiates Coverage On
10 months ago
Ocular Therapeutix IncOCUL
4Strong Buy$20.00N/AMaintains
a year ago
Tg Therapeutics IncTGTX
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Geron CorpGERN
1Strong Buy$10.00N/AInitiates Coverage On
3 years ago
Fusion Pharmaceuticals IncFUSN
1HoldN/AN/ADowngrades
3 years ago
Harpoon Therapeutics IncHARP
2HoldN/AN/ADowngrades
3 years ago
Merus NvMRUS
1BuyN/AN/AInitiates Coverage On
3 years ago
Bicycle Therapeutics PLCBCYC
1BuyN/AN/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.